Agencourt, Ambion Pen Reagent Distribution Deal

Sep 16, 2003

NEW YORK, Sept. 16 (GenomeWeb News) - Agencourt Bioscience said today that it has signed a distribution agreement with Ambion for its SPRI (Solid-Phase Reversible Immobilization) nucleic acid purification reagent.

Under the terms of the agreement, Ambion will distribute the reagent, called AMPure, as part of its MessageAmp RNA amplification kit.

Further details about the agreement were not provided.

Breaking News

Acutis Diagnostics to Integrate Sophia Genetics Analytics Into Hereditary Cancer NGS Assay
Reactivated Promoters in Transposable Elements Help Form Unique Tumor Antigens
Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies
Lucira Health Combo Flu/COVID-19 MDx Test Gets Regulatory Approval in Australia
Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.